A provider of after-school math tutoring, Four Seasons grew at 55% in the 1H17 with an impressive 35% EBITDA margin, but its concentration in Shanghai has started to cut into enrollment growth. Both biotech IPOs this week are developing drugs that inhibit …
( read original story …)